|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Encephalopathy, Autoimmune Evaluation, Spinal Fluid
Test CodeENC2M
Alias/See Also
AMPA-R Antibody CBA; Amphiphysin Antibody; Anti-Glial Nuclear Antibody, Type 1; Anti-Neuronal Nuclear Antibody, Type 1; Anti-Neuronal Nuclear Antibody, Type 2; Anti-Neuronal Nuclear Antibody, Type 3; Behavioral Change; CASPR2-IgG; Confusion; Contactin-Associated Protein-Like-2 (CASPR2)-IgG; CRMP-5-IgG; DPPX; dipeptidyl aminopeptidase-like protein 6; ENCEC; Encephalitis; GABA-B-R Antibody CBA; Glutamic Acid Decarboxylase (GAD65); Leucine-Rich Glioma Inactivated Protein-1 IgG; LGI1-IgG; metabotropic glutamate receptor 1; mGluR1; NMDA-R Antibody CBA; Psychosis; Purkinje Cell Cytoplasmic Antibody, Type 1; Purkinje Cell Cytoplasmic Antibody, Type 2; Purkinje Cell Cytoplasmic Antibody, Type Tr; Limbic encephalitis
Preferred Specimen
4 mL CSF
Minimum Volume
2 mL CSF
Transport Container
Sterile vial
Transport Temperature
Refrigerated (preferred)
Specimen Stability
Room Temperature: 72 hours
Refrigerated: 28 days
Frozen: 28 days
Refrigerated: 28 days
Frozen: 28 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Grossly hemolyzed, lipemic, or icteric specimens should be rejected.
Performing Laboratory
Mayo Clinic Laboratories sendout
Additional Information
Mayo Clinical Laboratories CSF Encephalopathy, Autoimmune Evaluation Information
Last Updated: December 3, 2021
